LMAT — Lemaitre Vascular Cashflow Statement
0.000.00%
Last trade - 00:00- $2.45bn
- $2.26bn
- $249.60m
- 95
- 19
- 97
- 81
Annual cashflow statement for Lemaitre Vascular, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 26.9 | 20.6 | 30.1 | 44 | 57.7 |
| Depreciation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 7.01 | 8.89 | 7.6 | 11 | 12.5 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -9.96 | -13.4 | -11.3 | -20.1 | -1.75 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Cash from Operating Activities | 35.1 | 25.4 | 36.8 | 44.1 | 81.3 |
| Capital Expenditures | -4.88 | -3.23 | -7.26 | -6.96 | -6.78 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -56.2 | -7.14 | -17.4 | -193 | -58.2 |
| Acquisition of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | -61.1 | -10.4 | -24.7 | -200 | -64.9 |
| Financing Cash Flow Items | -0.401 | -1.07 | 0 | -1.51 | -1.43 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 13.7 | -9.23 | -7.13 | 158 | -14.5 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -12.9 | 5.28 | 5.13 | 1.34 | 2.63 |